From ‘Ghar ke Nuskhe’ to unnecessary supplements: Why it’s crucial to be mindful of your dietary choices

Bipolar Disorder Resource Center

What Does Delta 8 Help With?

Disclaimer: This post contains affiliate links. 

Looking for a natural remedy that packs a punch? Enter delta 8, the cannabinoid with serious therapeutic potential. Whether you're dealing with health conditions or pesky symptoms, delta 8 might just be the game-changer you've been searching for. Say goodbye to traditional medications and hello to an alternative that's gaining popularity for its potential healing properties.

Delta 8 is capturing attention as people flock to explore its benefits. From pain relief to anxiety management, this cannabinoid offers a promising solution without the unwanted side effects of conventional drugs. So why not join the growing number of individuals who are embracing delta 8's potential? It's time to discover what this remarkable compound can do for you.

Don't settle for less. In the following sections, we'll delve into how delta 8 could help alleviate various health conditions and symptoms. Get ready to unlock nature's secrets and take charge of your health journey like never before!

Recommended Delta 8 Products

Everest Delta 8 Gummies

Budpop Delta 8 Gummies

Exhale Wellness Delta 8 Gummies

3CHI Delta 8 Gummies

Otterspace Delta 8 Gummies

Exploring the Therapeutic Potential of Delta 8

Delta 8, a lesser-known cannabinoid, is gaining attention for its potential therapeutic properties. Research suggests that this compound may have anti-inflammatory effects, making it a possible treatment option for various conditions characterized by inflammation.

One area where delta 8 shows promise is in managing chronic pain. Chronic pain conditions, such as arthritis or fibromyalgia, can significantly impact an individual's quality of life. Studies indicate that delta 8 may help alleviate pain by interacting with the body's endocannabinoid system. By binding to specific receptors in the central nervous system, delta 8 could potentially reduce pain signals and provide relief to those suffering from persistent discomfort.

Beyond its potential analgesic properties, delta 8 has also been studied for its neuroprotective effects. Neurodegenerative disorders like Alzheimer's disease and Parkinson's disease are characterized by the progressive deterioration of brain cells. Preliminary research suggests that delta 8 might offer some protection against these conditions by preventing cell damage and promoting neuronal health.

Furthermore, certain neurological disorders may benefit from the therapeutic potential of delta 8. One such condition is epilepsy—a disorder characterized by recurrent seizures. While more research is needed in this area, early studies indicate that delta 8 might possess anticonvulsant properties, potentially reducing seizure activity and improving overall seizure control.

In addition to epilepsy, other neurological disorders like multiple sclerosis (MS) and Tourette syndrome might also benefit from delta 8 treatment. MS is an autoimmune disease that affects the central nervous system, leading to various symptoms including muscle spasms and pain. Delta 8's potential anti-inflammatory effects could help alleviate these symptoms and improve the quality of life for individuals living with MS.

Tourette syndrome is a neurological disorder characterized by involuntary movements and vocalizations known as tics. Delta 8's ability to interact with the endocannabinoid system may offer relief by modulating the neurotransmitters involved in tic expression.

While delta 8 shows promise in various therapeutic areas, it is important to note that research is still in its early stages. More extensive studies are necessary to fully understand its potential benefits and establish appropriate dosing guidelines. It is always recommended to consult with a healthcare professional before considering any cannabinoid-based treatment.

Managing Pain and Inflammation with Delta 8

Delta 8, a lesser-known cannabis compound, has gained attention for its potential benefits in managing pain and inflammation. Many individuals have found relief from various types of discomfort by incorporating delta 8 into their wellness routines. Let's explore how this compound may help alleviate pain caused by inflammation and its potential applications in different conditions.

Relief from Inflammatory Pain

One of the primary benefits associated with delta 8 is its ability to provide relief from pain caused by inflammation. Inflammation is a natural response triggered by the immune system to protect the body against injury or infection. However, chronic inflammation can lead to persistent pain and discomfort.

Delta 8 interacts with the body's endocannabinoid system (ECS), which plays a crucial role in regulating various physiological functions, including pain perception and inflammation. By binding to ECS receptors, delta 8 may help reduce inflammatory responses, thereby alleviating the associated pain.

Managing Arthritis Discomfort

Arthritis is a common condition characterized by joint inflammation and stiffness that affects millions of people worldwide. The chronic nature of arthritis often leads to ongoing discomfort and reduced mobility. Fortunately, some individuals have reported finding relief from arthritis symptoms through delta 8 usage.

The analgesic properties of delta 8 make it a potential option for managing arthritis-related pain. By targeting the ECS receptors involved in pain regulation, delta 8 could potentially reduce joint discomfort and improve the overall quality of life for those living with arthritis.

Alleviating Migraines and Headaches

For individuals who suffer from migraines or frequent headaches, finding effective relief can be challenging. Delta 8 has been reported as beneficial for some individuals in managing these debilitating conditions.

While more research is needed to fully understand how delta 8 works on migraines and headaches, anecdotal evidence suggests that it may help reduce the severity and frequency of episodes. This could be attributed to delta 8's potential to modulate pain perception and alleviate inflammation, both of which play a role in migraines and headaches.

A Possible Option for Pain Management

Delta 8's analgesic properties make it an intriguing option for those seeking alternative methods of pain management. Whether it is discomfort caused by inflammation, arthritis-related pain, or migraines, delta 8 shows promise in providing relief.

It is important to note that individual experiences may vary, and consulting with a healthcare professional before incorporating delta 8 into your routine is advisable. They can provide personalized guidance based on your specific needs and medical history.

Delta 8 and Anxiety: Can It Help Relieve Symptoms?

Early studies suggest that delta 8 might have anxiolytic effects. Individuals who have used delta 8 report feeling calmer and more relaxed after consumption, indicating its potential to alleviate anxiety symptoms. This cannabinoid is gaining popularity among those seeking a natural way to manage their anxiety.

One of the main reasons people turn to delta 8 is because it may help reduce anxiety without the psychoactive intensity associated with delta 9 THC, which is found in higher concentrations in marijuana. While delta 9 THC can sometimes induce feelings of paranoia or increased anxiety, delta 8 offers a milder experience that many find more manageable.

Delta 8 interacts with the body's endocannabinoid system (ECS), which plays a crucial role in regulating various physiological functions, including mood and stress responses. By binding to the ECS receptors, delta 8 may help modulate these processes and promote a sense of calmness.

Anecdotal evidence suggests that delta 8 has been effective in reducing social anxiety and general feelings of unease. Many users have reported experiencing relief from symptoms such as racing thoughts, restlessness, and excessive worry after consuming products containing this compound.

Moreover, some individuals prefer using delta 8 over traditional anti-anxiety medications due to its perceived natural properties. They appreciate having an alternative option that doesn't involve potentially harsh pharmaceuticals or their associated side effects.

While scientific research on the specific effects of delta 8 on anxiety is still limited, early findings are promising. For instance, a study published in the journal "Cannabis and Cannabinoid Research" found that mice treated with low doses of delta 8 exhibited reduced anxiety-like behaviors compared to those given a placebo.

It's important to note that everyone's response to cannabinoids can vary, so individual experiences may differ. Factors such as dosage, product quality, metabolism, and personal biochemistry can influence the effects of delta 8 on anxiety symptoms.

Enhancing Sleep Quality with Delta 8 THC

Some individuals find that delta 8 helps improve their sleep quality. It might promote deeper, more restful sleep patterns. Delta 8 could potentially assist in regulating sleep-wake cycles. Users often report waking up feeling refreshed after using delta 8.

Sleep is an essential aspect of our overall well-being, and getting enough quality rest is crucial for maintaining good health. However, many people struggle with various sleep-related issues, such as insomnia or difficulty achieving a deep and restorative slumber. This is where delta 8 THC comes into play as a potential solution to enhance sleep quality.

Delta 8 THC has gained popularity among individuals seeking a natural alternative to aid their sleep troubles. Many users have reported experiencing improvements in their sleep patterns after incorporating delta 8 into their routine. By interacting with the body's endocannabinoid system, delta 8 may help regulate the sleep-wake cycle and promote more consistent and refreshing slumber.

One of the primary reasons why some individuals turn to delta 8 for better sleep is its ability to induce deeper and more restful states of relaxation. Unlike traditional sedatives or sleeping pills that can leave you feeling groggy or drowsy upon waking up, delta 8 offers a gentle approach to promoting high-quality rest without unwanted side effects.

By calming the mind and soothing the body, delta 8 THC can potentially help users achieve a state of tranquility conducive to falling asleep faster and staying asleep longer. Many people who struggle with racing thoughts or anxiety at night have found relief through the use of delta 8 products specifically formulated for enhancing sleep quality.

Furthermore, delta 8 may assist in regulating circadian rhythms—the internal clock responsible for controlling our sleep-wake cycles—by interacting with CB1 receptors in the brain. This interaction can help synchronize these rhythms, allowing users to establish healthier sleeping habits over time.

Users who have incorporated delta 8 into their nightly routine often report waking up feeling refreshed and rejuvenated. This is likely due to the improved sleep quality they experience, which allows for more profound restorative processes to occur during the night. Delta 8 THC has the potential to enhance the overall sleep experience, leaving individuals feeling more energized and ready to tackle the day ahead.

Delta 8 for Appetite Stimulation and Weight Management

Delta 8, a compound derived from hemp plants, has gained attention for its potential benefits in various areas of health and wellness. One notable area is its ability to stimulate appetite and aid in weight management. Whether you're struggling with poor appetite due to medical conditions or treatments like chemotherapy, or seeking support for managing eating disorders such as anorexia nervosa, delta 8 could potentially offer some relief.

For individuals dealing with medical conditions that cause a loss of appetite or significant weight loss, delta 8 may be a game-changer. Some people find it challenging to maintain a healthy weight when their appetite is diminished. However, delta 8 can help stimulate the desire to eat, allowing them to regain their lost appetite and potentially prevent further weight loss.

In cases where eating disorders are present, such as anorexia nervosa, delta 8 might also play a role in managing these conditions. Eating disorders often involve distorted body image perceptions and severe restrictions on food intake. By stimulating the appetite, delta 8 could help those with eating disorders develop healthier relationships with food and promote more balanced eating habits.

One of the advantages reported by users of delta 8 is its ability to help maintain a balanced appetite. Rather than experiencing extreme hunger or feeling constantly full, they find that delta 8 helps regulate their desire for food more naturally. This balance can be particularly beneficial for individuals who struggle with overeating or emotional eating patterns.

It's important to note that while there are anecdotal reports supporting the use of delta 8 for appetite stimulation and weight management, scientific research on this specific topic is limited. As with any supplement or alternative treatment approach, it's crucial to consult with a healthcare professional before incorporating delta 8 into your routine.

Boosting Mood and Easing Depression with Delta 8

Delta 8, a cannabinoid found in cannabis plants, has gained attention for its potential mood-enhancing properties. Many individuals have reported that delta 8 may help alleviate symptoms of depression and promote feelings of happiness and well-being. Unlike its cousin delta 9 THC, delta 8 is said to offer these benefits without the intense psychoactive effects.

For those seeking a natural alternative for mood support, delta 8 could be an appealing option. Its potential to boost mood has been attributed to its interaction with the body's endocannabinoid system, which plays a role in regulating various physiological processes including mood and emotions.

One of the key advantages of using delta 8 is its ability to provide mood enhancement without the overwhelming high associated with delta 9 THC. Some individuals find that traditional marijuana strains containing high levels of delta 9 THC can induce anxiety or paranoia, which can worsen symptoms of depression. Delta 8 offers a more gentle experience, allowing users to enjoy the benefits without feeling overwhelmed.

Individuals who have used delta 8 have reported improved motivation and increased positivity after consumption. This could be particularly beneficial for those struggling with depressive symptoms that often include a lack of energy or interest in activities. By promoting motivation and positivity, delta 8 may help individuals regain their zest for life and engage more fully in daily activities.

It's important to note that while many people find relief from depression symptoms through the use of cannabinoids like delta 8, it is not a cure-all solution. Depression is a complex mental health condition that can have multiple underlying causes. It is always recommended to consult with a healthcare professional before incorporating any new substance into your wellness routine.

Delta 8 for Nausea and Vomiting: A Promising Solution?

Preliminary research suggests that delta 8 may help reduce nausea and vomiting. This cannabinoid, derived from hemp or cannabis plants, has shown potential in managing these distressing symptoms. While more studies are needed to fully understand its effectiveness, many individuals have reported positive experiences with delta 8.

For those undergoing chemotherapy or experiencing motion sickness, delta 8 could be beneficial. Chemotherapy often leads to severe nausea and vomiting as a side effect. Finding relief from these symptoms is crucial for patients to maintain their quality of life during treatment. Some anecdotal evidence suggests that delta 8 may provide relief by interacting with the body's endocannabinoid system, which plays a role in regulating nausea and vomiting.

Similarly, individuals prone to motion sickness might find delta 8 helpful. Whether it's traveling by car, boat, or plane, motion sickness can turn a pleasant journey into an uncomfortable experience. Delta 8's potential antiemetic properties may alleviate the queasiness associated with motion sickness.

Moreover, pregnant women experiencing morning sickness could potentially benefit from delta 8. Morning sickness affects many expectant mothers during the early stages of pregnancy and can make daily life challenging. While there is limited scientific research specifically on delta 8 and morning sickness, some users claim that it helps them manage their symptoms effectively.

Many users find delta 8 helpful in managing symptoms of nausea or vomiting. Its potential antiemetic effects have gained popularity among those seeking alternative remedies for these discomforts. The compound interacts with the CB1 receptors in the endocannabinoid system, which are known to play a role in regulating nausea and vomiting.

While scientific studies on delta 8 are still emerging, anecdotal evidence suggests its efficacy in reducing nausea and vomiting. However, it is essential to consult with a healthcare professional before incorporating any new substance into your wellness routine, especially during pregnancy or while undergoing medical treatments.

Best Delta 8 Products Everest Delta 8 Gummies

Looking for the best delta 8 products on the market? Look no further than Everest Delta 8 Gummies. These delicious gummies are infused with high-quality delta 8 THC, offering a convenient and enjoyable way to experience its benefits.

Everest Delta 8 Gummies are known for their potency and effectiveness. Each gummy contains a precise dosage of delta 8 THC, allowing you to easily control your intake. Whether you're a beginner or an experienced user, these gummies cater to all levels of tolerance.

The effects of Everest Delta 8 Gummies can be described as uplifting and euphoric. Many users report feeling a sense of relaxation and stress relief after consuming these gummies. They can help alleviate anxiety, promote better sleep, and enhance overall mood.

Budpop Delta 8 Gummies

Another top contender in the world of delta 8 products is Budpop Delta 8 Gummies. These gummies are crafted with care, using only premium ingredients to ensure a high-quality experience.

Budpop Delta 8 Gummies come in various flavors that tantalize your taste buds while delivering the desired effects. From fruity options like strawberry and watermelon to classic favorites like blue raspberry, there's something for everyone.

These gummies offer a balanced blend of relaxation and focus. They can provide relief from pain and inflammation while promoting mental clarity and creativity. Whether you're looking to unwind after a long day or boost productivity during work hours, Budpop Delta 8 Gummies have got you covered.

Exhale Wellness Delta 8 Gummies

If you're searching for delta 8 products that prioritize natural ingredients and holistic wellness, look no further than Exhale Wellness Delta 8 Gummies. These gummies are made with organic hemp extract sourced from trusted farms, ensuring purity and potency.

Exhale Wellness Delta 8 Gummies are a popular choice among those seeking relief from chronic pain and discomfort. The delta 8 THC in these gummies interacts with the body's endocannabinoid system, helping to reduce inflammation and promote relaxation.

These gummies also offer potential benefits for mental health. Many users report experiencing reduced anxiety and improved mood after consuming Exhale Wellness Delta 8 Gummies. They can be a valuable tool in managing stress and finding balance in daily life.

3CHI Delta 8 Gummies

3CHI Delta 8 Gummies are hard to beat. These gummies are crafted with precision, ensuring consistent dosing and quality across each piece.

3CHI Delta 8 Gummies are known for their potent effects. They can provide a powerful sense of relaxation while maintaining mental clarity. These gummies are perfect for unwinding after a long day or simply taking a moment to destress.

The versatility of these gummies makes them suitable for various purposes. Whether you're looking to enhance your creativity, alleviate pain, or improve sleep quality, 3CHI Delta 8 Gummies offer a reliable solution.

Otterspace Delta 8 Gummies

Last but not least on our list of the best delta 8 products are Otterspace Delta 8 Gummies. These gummies stand out with their unique flavors and exceptional quality.

Conclusion: The Benefits of Delta 8

In conclusion, delta 8 offers a range of potential benefits across various therapeutic areas. While more research is needed to fully understand its effects, many users have reported positive experiences with this unique compound. If you are considering trying delta 8 products, make sure to do your research and choose high-quality options from trusted brands.

FAQs Q: Can delta 8 help with chronic pain?

Delta 8 has shown potential in managing pain due to its analgesic properties. However, individual experiences may vary. It is recommended to consult with a healthcare professional before using any new product for pain management.

Q: Is delta 8 safe to use?

While generally considered safe, it's important to buy delta 8 products from reputable sources that undergo third-party testing for purity and potency. Adhering to recommended dosages and consulting with a healthcare professional can also help ensure safe usage.

Q: How long does it take for delta 8 effects to kick in?

The onset time can vary depending on the individual and the method of consumption. Inhalation methods tend to have quicker effects (within minutes), while edibles may take longer (up to an hour or more) due to digestion processes.

Q: Can I drive after consuming delta 8?

It is advised not to drive or operate heavy machinery after consuming delta 8 THC as it may impair coordination and reaction times. Always prioritize safety and wait until the effects have worn off before engaging in activities that require full attention.

Q: Are there any side effects of delta 8?

While side effects may vary from person to person, some commonly reported side effects of delta 8 include dry mouth, red eyes, and increased heart rate. It is important to start with a low dosage and monitor your body's response.

Q: Can I use delta 8 for anxiety?

Delta 8 has shown potential in alleviating symptoms of anxiety, but individual experiences may vary. It is recommended to consult with a healthcare professional to determine the best course of action for managing anxiety.

Addressing Unmet Needs In Treating A Wide Range Of Neurological Disorders

XWPharma is a biopharmaceutical company dedicated to the discovery and development of potential first- and best-in-class medicines with unique features to address the medical needs of patients suffering from debilitating neurological diseases. The company, which has offices in the United States, China, and Taiwan, has created novel therapies that leverage mechanisms of action that have been validated as highly effective in clinical studies and medical practice.

The goal of this drug discovery approach is to achieve therapeutic efficacy while avoiding side effects associated with available treatments. Ultimately, this strategy will increase the odds that these internally discovered medicines will succeed in clinical testing and commercialization. The company's two clinical-stage programs focus on the development of XW10172 for sleep dysfunction, and XW10508 for treatment-resistant depression and chronic pain.

"XWPharma has built a highly productive drug discovery platform, capitalizing on its extensive experience with proprietary techniques to improve pharmacology," said president and chief executive officer, Leonard Blum. "The company's current pipeline is evidence of its capability to generate multiple exciting new investigational drugs for patients with severely debilitating neurological disorders."

Superior sleep without side effects

Sleep abnormalities are common across neurodegenerative diseases, affecting more than one million people in the United States alone. Typically, patients experience a reduction in slow-wave sleep and frequent episodes of rapid-eye-movement (REM) sleep. This fragmented sleep architecture can result in excessive daytime sleepiness, multiple awakenings, fatigue, insomnia, spontaneous daytime dozing, and hallucinations.

Narcolepsy is a life-long disease characterized by fragmented sleep which manifests primarily as excessive daytime sleepiness and cataplexy—sudden and uncontrollable muscle weakness or paralysis. It is considered an orphan disease in the United States, affecting between 165,000 and 185,000 people. Agonists of gamma-aminobutyric acid (GABAB) receptors, which are indicated for the treatment of narcolepsy, currently represent more than $1.7 billion in annual sales in the United States.

The majority of patients with Parkinson's disease also experience sleep problems. Nearly half a million patients in the United States experience fatigue and excessive daytime sleepiness. These symptoms often manifest at early disease stages, and negatively impact both productivity and quality of life. In the United States, no treatments have been approved by the Food and Drug Administration (FDA) for sleep disorders resulting from Parkinson's disease. Currently available treatment options either have poor efficacy or cause adverse events such as anxiety and a rise in blood pressure.

To address this significant unmet need, XWPharma has developed the GABAB agonist XW10172 as a superior alternative to sodium oxybate, which is FDA approved for the treatment of cataplexy or excessive daytime sleepiness in patients with narcolepsy. Sodium oxybate has also demonstrated efficacy for normalizing sleep architecture and improving sleep outcomes in patients with Parkinson's disease.

In contrast to sodium oxybate, XW10172 contains no sodium and therefore poses no excess cardiovascular risk. Moreover, XW10172 requires only one dose at night rather than the twice-nightly dosing used for sodium oxybate.

XW10172 is a stabilized form of oxybate consisting of a high concentration of uniformly small and spherical granules, which are ideal for yielding predictable release (Fig. 1). In addition, absorption occurs in the small intestine within four to six hours, avoiding late-stage absorption in the large intestine. Together, these optimized drug design features will lead to fast sleep onset, sustained sleep during the night, and low concentrations at waking hours to prevent any hangover effect.

XW10172 has completed phase 1 clinical trials. XWPharma expects to release this data soon and initiate phase 2 studies in patients with Parkinson's disease. In addition, a single pivotal phase 3 trial is planned for patients with narcolepsy. The orphan drug designation is expected to expedite further development of XW10172 for narcolepsy. The FDA grants orphan status to promising investigational drugs designed to treat, prevent, or diagnose rare medical diseases or conditions that affect fewer than 200,000 individuals in the United States.

"In just over three years, we went from an idea to first-in-human clinical trials," said XWPharma's founder and Chief Scientific Officer Jia-Ning Xiang. "This demonstrates that our platform technology can deliver better compounds into the clinic in a shorter time than traditional Research and Development approaches for neurological disorders."

Fig. 1Distinctive features of XWPharma's candidate XW10172.

Safer solution for common conditions

Treatment-resistant depression and chronic pain are both highly prevalent and debilitating conditions. More than 264 million people worldwide suffer from major depressive disorder, and one-third of these patients are considered treatment-resistant, failing two or more antidepressants.

One in five people around the world experience chronic pain. In the United States alone, more than 20 million people have high-impact chronic pain, which frequently limits life or work activities. Despite therapies available, significant needs remain in treating both disorders, and a large number of patients are unable to find relief from existing options.

N-methyl-d-aspartate (NMDA) receptor antagonists such as intravenous ketamine and intranasal esketamine are proven to be effective for treating patients who have major depressive disorder or chronic pain, and do not respond to other forms of therapy. Spravato is an esketamine therapy that works quickly and has lasting efficacy, but it requires administration under supervision of a healthcare provider, and can lead to adverse events such as dissociation, sedation, and high blood pressure. These side effects peak at 60 minutes, and can last between four and six hours.

To address these limitations, XWPharma developed XW10508 as an esketamine-based therapy with an optimized therapeutic index. XW10508 is a glutamatergic NMDA antagonist and AMPA activator designed for the treatment-resistant depression and chronic pain. Unlike Spravato, XW10508 is an oral therapy that slowly releases esketamine over a longer time period. Due to its improved pharmacokinetics, XW10508 has the potential to avoid adverse events such as dissociation, sedation, and high blood pressure, while providing lasting relief from depression and chronic pain (Box 1).

Box 1Favorable characteristics of XW10508.

• Good oral bioavailability shown across multiple nonclinical species

• Absorption throughout the gastrointestinal tract to enable once-daily dosing

• Compound inactive until metabolization in liver, preventing rapid onset of effect following alternative means of delivery directly into the blood stream

Compelling evidence suggests that lower concentrations of ketamine or esketamine can be effective for the treatment of depression. Moreover, XW10508 has improved bioavailability, extended absorption throughout the entire gastrointestinal tract for once-daily administration, and is inactive upon ingestion until it is metabolized in the liver. These unique pharmacological properties minimize the risk of abuse (Fig. 2).

XW10508 has completed FDA Investigational New Drug (IND)-enabling studies, and is expected to enter the clinic in the second quarter of 2021 for the assessment of safety and tolerability. By the middle of next year, XWPharma plans to release phase 2a trial data for patients with treatment-resistant depression and chronic pain.

Fig. 2Distinctive features of XWPharma's candidate XW10508.

Talented team

The successful discovery and development of these two lead drug candidates would not have been possible without the efforts of the company's senior leadership team, including Blum, Xiang, and Chief Medical Officer, Daniel Canafax.

Xiang launched XWPharma in 2014. From 2007 to 2013, he was the senior director of Integrated Platform & Sciences and the head of Medicinal Chemistry at the GlaxoSmithKline Neuroscience Center in Shanghai. He was director of Medicinal Chemistry at XenoPort from 2001 to 2007. Prior to that, he spent nine years at SmithKline Beecham, holding various positions, most recently as assistant director of Medicinal Chemistry. Xiang holds 62 issued United States patents and contributed to nine compounds that were studied in clinical trials of central nervous system disorders, including the marketed drug, Horizant, for the treatment of restless legs syndrome and neuropathic pain.

"I am thrilled to work on expanding XWPharma's footprint in the United States and rapidly advancing our transformative therapeutics through development, registration and launch," Xiang said.

Canafax has been XWPharma's chief medical officer since 2018. He has more than 22 years of experience in the pharmaceutical industry, leading clinical drug development from concept, preclinical studies, and clinical studies through marketing approval and post-marketing research. Canafax has significant expertise in designing and monitoring studies for developing new drug therapies for central nervous system disorders, immunosuppression, renal diseases, gastrointestinal diseases, infectious diseases, and other indications.

"I am delighted to lead the clinical development of new drugs with the potential to benefit many patients in the near future," Canafax said. "I look forward to continuing to work closely with Jia-Ning Xiang and the entire XWPharma management team, the medical community, and the patients in need of new therapies. We will work diligently to provide new treatment options for the millions of patients who suffer from neurologic diseases."

Before joining XWPharma in April 2020, Blum founded, built, and led commercial organizations at a series of emerging growth biopharmaceutical companies, including ICOS Corp. (acquired by Eli Lilly), Theravance, Omeros Corp., and Madrigal Pharmaceuticals. From 1987 to 2000, he progressed through marketing, sales, and business leadership roles at Merck and Co. Over the past 33 years, Blum has been responsible for national and global launches, turnarounds, and rapid sales acceleration for more than 20 medicines in a wide variety of therapeutic categories, including specialty products and blockbusters. His work has earned multiple industry accolades, and is the subject of two Harvard Business School case studies.

"Our team brings together decades of drug discovery, development and commercialization expertise with a notable track record of success," Blum said. "We share a commitment to bring forward truly original medicines for treating sleep disorders, treatment-resistant depression, chronic pain and other disease states that continue to present huge and underserved challenges for patients, healthcare systems, and societies around the world."

Evolving opportunities

XWPharma remains focused on advancing its two lead drug candidates through clinical trials. Meanwhile, the company is also developing potential treatments for epilepsy, neuropathic pain, amyotrophic lateral sclerosis, and gastroparesis.

XWPharma pursues efficient development pathways that are designed to de-risk each program at an early stage of clinical development. Each therapy targets high value commercial markets with favorable reimbursement and market access. Moreover, all therapies in clinical development are new chemical entities with distinctive features and composition-of-matter patent protection.

To date, the company has raised more than $63 million from leading healthcare investors in the United States and Asia. Investors include Kleiner Perkins, Johnson & Johnson Innovation, WuXi AppTec, WI Harper Group and others.

Currently, XWPharma is seeking opportunities for partnership and commercialization at all stages of drug development, both in the United States and in China. "These partnerships will be invaluable as we prioritize the multiple high potential opportunities our research unit has identified and navigate the evolving therapeutics landscape of creating first-of-their-kind therapeutics for patients suffering from neurological disorders with compelling unmet needs," Blum said.

---